Bibliographic Details
| Title: |
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases. |
| Authors: |
Wang, Dong1 (AUTHOR), Tabti, Redouane2 (AUTHOR), Elderwish, Sabria2 (AUTHOR), Abou-Hamdan, Hussein2 (AUTHOR), Djehal, Amel2,3 (AUTHOR), Yu, Peng1 (AUTHOR), Yurugi, Hajime4 (AUTHOR), Rajalingam, Krishnaraj4 (AUTHOR), Nebigil, Canan G.2 (AUTHOR), Désaubry, Laurent1,2 (AUTHOR) desaubry@unistra.fr |
| Source: |
Cellular & Molecular Life Sciences. Sep2020, Vol. 77 Issue 18, p3525-3546. 22p. 20 Diagrams, 1 Chart. |
| Subject Terms: |
*NEUROLOGICAL disorders, *HEART diseases, *SCAFFOLD proteins, *LIGANDS (Biochemistry), *CANCER, *PROGRAMMED cell death 1 receptors |
| Abstract: |
Over the last three decades, the scaffold proteins prohibitins-1 and -2 (PHB1/2) have emerged as key signaling proteins regulating a myriad of signaling pathways in health and diseases. Small molecules targeting PHBs display promising effects against cancers, osteoporosis, inflammatory, cardiac and neurodegenerative diseases. This review provides an updated overview of the various classes of PHB ligands, with an emphasis on their mechanism of action and therapeutic potential. We also describe how these ligands have been used to explore PHB signaling in different physiological and pathological settings. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cellular & Molecular Life Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
